Literature DB >> 12181217

Assessment of myocardial adrenergic innervation in patients with sick sinus syndrome: effect of asynchronous ventricular activation from ventricular apical stimulation.

M E Marketou1, E N Simantirakis, V K Prassopoulos, S I Chrysostomakis, A A Velidaki, N S Karkavitsas, P E Vardas.   

Abstract

OBJECTIVE: To investigate ventricular sympathetic innervation in patients with sick sinus syndrome and to detect regional deterioration of adrenergic innervation caused by asynchronous ventricular activation from right ventricular pacing.
DESIGN: Prospective controlled study.
SETTING: Tertiary cardiac referral centre. PATIENTS: 22 patients with sick sinus syndrome and indications for permanent dual chamber pacing; 20 healthy individuals as controls.
INTERVENTIONS: All patients underwent myocardial imaging with planar and single photon emission computed tomography (SPECT) after an intravenous infusion of 5 mCi 123I-meta-iodobenzylguanidine (123I-MIBG) before and after pacemaker implantation. A SPECT thallium201 myocardial study was done during the same week as the 123I-MIBG study in all patients. MAIN OUTCOME MEASURES: The heart to mediastinum (H/M) ratio and washout rate were calculated during the 123I-MIBG study to assess the global cardiac sympathetic activity; the aim of the SPECT study was to investigate the regional distribution of adrenergic innervation.
RESULTS: The H/M ratio was significantly smaller in the patients with sick sinus syndrome than in the controls (p < 0.001). In sick sinus syndrome there were regional adrenergic innervation defects, mostly in the inferior and apical walls. After a medium term pacing period, a redistribution of 123I-MIBG uptake was detected, with deterioration of adrenergic innervation in the inferior, apical, and posterior walls. The thallium201 myocardial perfusion study showed no change after three months of permanent pacing.
CONCLUSIONS: Patients with sick sinus syndrome have global and regional disturbances of the adrenergic innervation of the left ventricular myocardium. These seem to deteriorate as a result of asynchronous electrical activation. The clinical significance of this finding requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181217      PMCID: PMC1767331          DOI: 10.1136/heart.88.3.255

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  24 in total

1.  Effects of asynchronous ventricular activation on myocardial adrenergic innervation in patients with permanent dual-chamber pacemakers; an I(123)-metaiodobenzylguanidine cardiac scintigraphic study.

Authors:  E N Simantirakis; V K Prassopoulos; S I Chrysostomakis; G E Kochiadakis; S I Koukouraki; J P Lekakis; N S Karkavitsas; P E Vardas
Journal:  Eur Heart J       Date:  2001-02       Impact factor: 29.983

2.  Septal ventricular pacing in the immature canine heart: a new perspective.

Authors:  P P Karpawich; C D Justice; C H Chang; C Y Gause; L R Kuhns
Journal:  Am Heart J       Date:  1991-03       Impact factor: 4.749

3.  Redistribution of myocardial fiber strain and blood flow by asynchronous activation.

Authors:  F W Prinzen; C H Augustijn; T Arts; M A Allessie; R S Reneman
Journal:  Am J Physiol       Date:  1990-08

4.  Effect of long-term atrial-demand ventricular pacing on cardiac sympathetic activity.

Authors:  S Fukuoka; S Nakagawa; T Fukunaga; H Yamada
Journal:  Nucl Med Commun       Date:  2000-03       Impact factor: 1.690

5.  Developmental sequelae of fixed-rate ventricular pacing in the immature canine heart: an electrophysiologic, hemodynamic, and histopathologic evaluation.

Authors:  P P Karpawich; C D Justice; D L Cavitt; C H Chang
Journal:  Am Heart J       Date:  1990-05       Impact factor: 4.749

6.  Scintigraphic assessment of regional cardiac adrenergic innervation.

Authors:  M W Dae; J W O'Connell; E H Botvinick; T Ahearn; E Yee; J P Huberty; H Mori; M C Chin; R S Hattner; J M Herre
Journal:  Circulation       Date:  1989-03       Impact factor: 29.690

7.  Regional myocardial blood flow in patients with sick sinus syndrome randomized to long-term single chamber atrial or dual chamber pacing--effect of pacing mode and rate.

Authors:  J C Nielsen; M Bøttcher; T T Nielsen; A K Pedersen; H R Andersen
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

8.  Right ventricular pacing reduces the rate of left ventricular relaxation and filling.

Authors:  M R Zile; A S Blaustein; G Shimizu; W H Gaasch
Journal:  J Am Coll Cardiol       Date:  1987-09       Impact factor: 24.094

9.  Myofibrillar disarray produced in normal hearts by chronic electrical pacing.

Authors:  G E Adomian; J Beazell
Journal:  Am Heart J       Date:  1986-07       Impact factor: 4.749

10.  Alteration of left ventricular performance by left bundle branch block simulated with atrioventricular sequential pacing.

Authors:  J Askenazi; J H Alexander; D I Koenigsberg; N Belic; M Lesch
Journal:  Am J Cardiol       Date:  1984-01-01       Impact factor: 2.778

View more
  4 in total

1.  Imaging of cardiac adrenergic innervation.

Authors:  P G Camici
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

Review 2.  Pacing-induced cardiomyopathy: pathophysiological insights through matrix metalloproteinases.

Authors:  Fozia Z Ahmed; Rajdeep S Khattar; Amir M Zaidi; Ludwig Neyses; Delvac Oceandy; Mamas Mamas
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

3.  Cardiac β-Adrenergic Receptor Downregulation, Evaluated by Cardiac PET, in Chronotropic Incompetence.

Authors:  Toshihiko Goto; Shohei Kikuchi; Kento Mori; Takafumi Nakayama; Hidekatsu Fukuta; Yoshihiro Seo; Hitomi Narita; Akihiko Iida; Nobuyuki Ohte
Journal:  J Nucl Med       Date:  2020-12-18       Impact factor: 10.057

Review 4.  Ventricular Dyssynchrony and Pacing-induced Cardiomyopathy in Patients with Pacemakers, the Utility of Ultra-high-frequency ECG and Other Dyssynchrony Assessment Tools.

Authors:  Jan Mizner; Pavel Jurak; Hana Linkova; Radovan Smisek; Karol Curila
Journal:  Arrhythm Electrophysiol Rev       Date:  2022-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.